{"ticker": {"uuid": "10391c94-4bf3-434f-82c8-44ae41f5e497", "symbol": "DBVT", "name": "DBV Technologies", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "DBV Technologies Q2 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/e60da475-1faa-3b60-9017-99d12ca01f96/dbv-technologies-q2-earnings.html", "source_name": "MarketBeat", "published_at": "2026-07-16T23:03:00+00:00", "published_display": "16 Jul 2026 23:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPQ181OW1ta3d0XzRxRFZzMDc0cHFNeXVzUUZRSmZSS0VQbXU1d2VpVU9qVmZXQUtxdkNGeDFvUVRhWnZpb0Ric2ozaWdzeGw2N0w1eDV0WUNJbEZNaEpDd2h6R3FZaHVyb2dXcHl0NFNNSFk1aXlhY3A2eUtFSnA5bE9iekd0NER3cUhTYkprdldoR203MlhpbkFQdmlpZHB1YzFfU2NVWnd1a2xtaGJnSVNJQUtPbXZaZ2JiaXcyUWFPeFk1ZmFxTmdnYjVSbkJyQVdoWkpMNnkzbklUS1QzX1lhZzFmT1pHZEk0?oc=5", "source_name": "markets.businessinsider.com", "published_at": "2026-07-16T21:27:15+00:00", "published_display": "16 Jul 2026 21:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies narrows Q2 loss, funds operations into Q3 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQeUF3VVNkMGZ1WDllcUFXOS1lM01pYUNCRDFIWDJkWmJJcVVudEZqZ3dPQlQwbklhN0pHdHZvampOUGE1NWZXOFRWaWtQWHFPSGdJWlRkc0NmMnV2R2c5LUl2bHIxLTE4ZXJvSk1CbDJUVUt4TnRmeW84YkJFcmRhYkxjZWpEVmdKRjluMlhaLWxjbmZOeXQ4c0Itb1pmclRBT0ZDX2dKbkZLRTJqSU0w?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-16T21:19:49+00:00", "published_display": "16 Jul 2026 21:19", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Announces the Filing of its 2026 Half-Year Report \u2015 Conditions for Accessing or Consulting the Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxPRkdVeW9xS1pIZWtSLWs5azlXMG1vNHhXVldCV0xHLTV3MFdLY01qUjdGSnZYT0syOHF2VU93SUlGbk9mbFhvLVhlUHZVTkpGZGJza1BJLS1oMGlpRUhGVmhuZlhOMWxZODVaZUYtblk0R2tIMmV0VlFWVlliM284WDVabmhGUHNmdjJhSHJ4d1B4OW5pZTFsamFpV2ZuRDAtS3hDQTdtWko5a1J0WnRRcFcwR28wWXBfUXZOYzNMOHpkZDR2N2RURDJ0ek9SLWg1SGxFeHRJTmhPdWkwUDZCejd1ZGpyVnA1V2F2Z3ROcUNBQWUtM05NeTdkZ1JfSlAxR1FaQmxB?oc=5", "source_name": "markets.businessinsider.com", "published_at": "2026-07-16T21:15:13+00:00", "published_display": "16 Jul 2026 21:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Q2 Net Loss Narrows", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/dbv-technologies-q2-net-loss-201457432.html", "source_name": "MT Newswires", "published_at": "2026-07-16T20:14:57+00:00", "published_display": "16 Jul 2026 20:14", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026", "summary": "DBV Technologies announced it will host a conference call and live audio webcast on July 16, 2026, at 5:00 p.m. ET to discuss", "url": "https://www.globenewswire.com/news-release/2026/07/14/3327300/0/en/dbv-technologies-to-report-second-quarter-2026-financial-results-and-business-update-on-july-16-2026.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T16:10:51", "published_display": "15 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Stock Breaks Its \u20ac2.75 Support Ahead of Semi-Annual Results", "summary": "DBV Technologies stock is experiencing a downward trend, breaking its \u20ac2.75 support and trading below its three moving averages ahead of its semi-annual results announcement. The biotech company's stock is down 3.03% during the session, and has fallen nearly 29% over three months", "url": "https://www.ideal-investisseur.fr/en/stock-news/dbv-technologies-stock-breaks-its-eur2-75-support-ahead-of-semi-annual-results/22647.html", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-07-15T10:40:47", "published_display": "15 Jul 2026 10:40", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies to report Q2 2026 results on July 16", "summary": "DBV Technologies is scheduled to release its second quarter 2026 financial results and provide a business update on July 16, 2026. The biopharmaceutical company will host a conference call and live webcast to discuss its performance. The company specializes in developing treatmen", "url": "https://scanx.trade/stock-market-news/companies/dbv-technologies-to-report-q2-2026-results-on-july-16/45613937", "source_name": "scanx.trade", "published_at": "2026-07-14T22:20:32", "published_display": "14 Jul 2026 22:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies' July 16 webcast will cover Q2 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOLWNOZE9wb0RTU3FHVkRqTnZJSnpDeS1uNVRLbTlhRlNtOENTY1ladHBxeUFxUVBTQkxod2xOWS1BV21iT0RFS0tVZmd4RjNDTnBRY0FMajFCeG52X3NzYTlhZU0tSzVhSDdwQnhkaURZQWVEYjdpTURNZXQ5QmJjUHhTOUVQZWlFU1NUQlFyLXZ4T010Slp6dVlkcDVmZmY3NVZGdWJZU0tkb2ZsMzloTi1iYlVZTExsd3JhczVCSWI?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:30:00+00:00", "published_display": "14 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Sets Q2 2026 Results Call July 16 | DBVT Stock News", "summary": "DBV Technologies announced it will report its second quarter 2026 financial results and provide a business update on July 16, 2026. The company will host an investor conference call and live audio webcast at 5:00 p.m. ET to review these results. Key details for investors include ", "url": "https://www.stocktitan.net/news/DBVT/dbv-technologies-to-report-second-quarter-2026-financial-results-and-00cwnf1ic3c7.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:20:32", "published_display": "14 Jul 2026 20:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies S.A. (DBVT) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live quotes and charts for DBV Technologies S.A. (DBVT) stock, showing a current price of $15.53 with a decrease of 2.45%. It also notes that earnings information is not currently available and lacks analyst ratings in the last three months. The content include", "url": "https://www.timothysykes.com/quote/DBVT/", "source_name": "www.timothysykes.com", "published_at": "2026-07-14T19:40:47", "published_display": "14 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in DBV Technologies SA Sponsored ADR Stocks", "summary": "This article lists Exchange Traded Funds (ETFs) that hold DBV Technologies SA Sponsored ADR stocks, sorted by market value. It provides key details for each fund, such as market value, weight, issuer, management style, expense ratio, and AUM, to help investors assess opportunitie", "url": "https://www.tradingview.com/symbols/NASDAQ-DBVT/etfs/", "source_name": "TradingView", "published_at": "2026-07-13T06:10:41", "published_display": "13 Jul 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPV1hqSFhQM3VfYlNsdldfeVQ1dEdNNzI3S1RTaFJNSThrOXlPSWpMTlR5WWVxNnNsTzhTVGVvTE94R18wa1A0OUdFczBlcTIzeUFBZUt6VVJJMjNqNks3dmRUSzB4cE40anpNekJwUXAwcTFEcVh4QVZCYURXY2w4b2thdk5KZ3ZJMnI1REJObXo5UDdISXVCU1Z2ZVZoVmJpbnEzaDVWVmpGQVNFZzRXYnp0SWRRWWZGSnZnWlJ4aEloNmJBNGRMVFRjb3ZRbmV3QXF5S0pvTV9xNnpaMWV1Z1ZtM3lPdV9RcEdURHlfZFphdjlicEJndW0ybHNBa205?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-13T03:32:00+00:00", "published_display": "13 Jul 2026 03:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Citizens JMP Maintains DBV Technologies(DBVT.US) With Buy Rating, Maintains Target Price $55", "summary": "Citizens JMP has reiterated its Buy rating for DBV Technologies (DBVT.US), maintaining a target price of $55. This indicates a continued positive outlook on the company's stock performance from the financial institution.", "url": "https://news.futunn.com/en/post/75318636/citizens-jmp-maintains-dbv-technologies-dbvtus-with-buy-rating-maintains", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-08T02:09:29", "published_display": "08 Jul 2026 02:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF", "summary": "DBV Technologies issued its half-year report for its liquidity contract with ODDO BHF, detailing transactions and assets from January 1, 2026, to June 30, 2026. The report showed an increase in DBV Technologies shares in the liquidity account and provided a breakdown of numerous ", "url": "https://www.globenewswire.com/news-release/2026/07/06/3322759/0/en/half-year-report-on-the-dbv-technologies-liquidity-contract-with-oddo-bhf.html", "source_name": "GlobeNewswire", "published_at": "2026-07-07T13:41:13", "published_display": "07 Jul 2026 13:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies S.A.", "summary": "DBV Technologies S.A. has issued its Half-Year Report on the liquidity contract with ODDO BHF for the period of January 1, 2026, to June 30, 2026. The report details the assets held in the liquidity account and the transactions executed within this timeframe, showing significant ", "url": "https://via.ritzau.dk/pressemeddelelse/15036760/dbv-technologies-sa?publisherId=90446", "source_name": "Via Ritzau", "published_at": "2026-07-06T20:14:46", "published_display": "06 Jul 2026 20:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies posts half-year liquidity contract figures", "summary": "DBV Technologies released its half-year report on the liquidity contract with ODDO BHF as of June 30, 2026. The report shows the liquidity account held 146,321 shares and \u20ac396,088.22, with significant trading volumes in the first half of 2026. This contract, governed by AMF Decis", "url": "https://www.stocktitan.net/news/DBVT/half-year-report-on-the-dbv-technologies-liquidity-contract-with-eidhndi1oiqa.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:10:57", "published_display": "06 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Stock Drops Over 2% and Breaks Its Support at \u20ac2.75", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQU3h4YjJvWHZpZzloU2FMdHRGUDd4WmV6OWltRXo4ZTl0bk1EOHk2TWotQTdmYnpsV2JTWkFudzhCU0VBOHdSV3ZVZENFa0tnM1dqVmlWZ19HR1d0ejd3cWstSmRjSjNKOWlGUDFSY0R6YWFuRjJEa2xSSVhYT19jUUtHMEJ0eWdXanB3MkYwNEJEejgwc0ZaT0FMdkdvUHdRTEZMNHF5VG5MSGYteUgtRzJwdnE5RXJKMTBjek1pQkVYWUlUMmhR?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim Maintains DBV Technologies(DBVT.US) With Buy Rating, Maintains Target Price $51", "summary": "Guggenheim has reiterated its Buy rating for DBV Technologies (DBVT.US) and maintained its target price at $51. This indicates continued confidence from the firm in the company's prospects.", "url": "https://news.futunn.com/en/post/75395876/guggenheim-maintains-dbv-technologies-dbvtus-with-buy-rating-maintains-target", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-02T00:13:19", "published_display": "02 Jul 2026 00:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Quick Look at Today's Ratings for DBV Technologies(DBVT.US), With a Forecast Between $40 to $55", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOcW1icEpuLXpVUzAyajEzVDF1UXlkdE5lU0JzV0JRUWUwY2VhMDBfRkZaS2w5V0Q5WjN0S0VaUTFOUFdDSEx6OG4xNXBPeGw5ZDhRbWV3NjlESUluS1dPd3RuVGlndDhSZ1k5ck9USHN3Z2FOQTZZYnRaX28wMzB0SFZoMW5OZ3dmdWNCS0c4dVlsbVZuV1lsQWJR?oc=5", "source_name": "Moomoo", "published_at": "2026-07-01T13:00:01+00:00", "published_display": "01 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Plans Q3 Filing of US Regulatory Application for Viaskin Peanut Patch", "summary": "DBV Technologies announced its intention to file a regulatory application with US health authorities for its Viaskin Peanut patch in the third quarter of 2026. This move follows a pre-submission meeting with the FDA, where the company confirmed the required data for resubmission.", "url": "https://www.moomoo.com/news/post/72229235/dbv-technologies-plans-q3-filing-of-us-regulatory-application-for?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-30T23:09:06", "published_display": "30 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of DBV Technologies SA \u2013 FWB:DBV", "summary": "This page provides financial information for DBV Technologies SA (FWB:DBV) from the Frankfurt Stock Exchange, specifically focusing on its enterprise value to revenue forward. The content indicates that the market is closed and there have been no recent trades. It is presented on", "url": "https://www.tradingview.com/symbols/FWB-DBV/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T19:39:48", "published_display": "30 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies delays BLA filing for VIASKIN\u00ae Peanut Patch in kids 4-7 to Q3 2026 after FDA feedback.", "summary": "DBV Technologies has announced a delay in filing its Biologics License Application (BLA) for the VIASKIN\u00ae Peanut Patch for children aged 4 to 7, pushing it to the third quarter of 2026. This postponement is a result of collaborative discussions with the FDA, aiming to optimize th", "url": "https://pluang.com/en/news-feed/dbv-technologies-update-pengajuan-bla-patch-kacang-anak-anak", "source_name": "Pluang", "published_at": "2026-06-29T21:10:59", "published_display": "29 Jun 2026 21:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Provides BLA Submission Update for the VIASKIN\u00ae Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing", "summary": "DBV Technologies announced an update on its Biologics License Application (BLA) submission for the VIASKIN\u00ae Peanut Patch for children aged four through seven years, following extensive discussions with the FDA. The company received valuable feedback regarding the organization and", "url": "https://www.manilatimes.net/2026/06/30/tmt-newswire/globenewswire/dbv-technologies-provides-bla-submission-update-for-the-viaskin-peanut-patch-in-children-aged-4-through-7-years-working-collaboratively-with-fda-to-optimize-review-process-in-preparation-for-filing/2375236/amp", "source_name": "The Manila Times", "published_at": "2026-06-29T20:10:59", "published_display": "29 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies to file VIASKIN Peanut Patch BLA in Q3 2026 after FDA feedback", "summary": "DBV Technologies plans to submit its Biologics License Application (BLA) for the VIASKIN Peanut Patch in Q3 2026, after incorporating feedback from the FDA. The company engaged in detailed discussions with the FDA, receiving guidance on CMC and biostatistics, with no requests for", "url": "https://www.tradingview.com/news/tradingview:f98bbd4f59988:0-dbv-technologies-to-file-viaskin-peanut-patch-bla-in-q3-2026-after-fda-feedback/", "source_name": "TradingView", "published_at": "2026-06-29T20:10:59", "published_display": "29 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies (NASDAQ: DBVT) targets Q3 2026 for VIASKIN Peanut BLA filing", "summary": "DBV Technologies announced an updated timeline for its Biologics License Application (BLA) for the VIASKIN Peanut Patch, now targeting Q3 2026 for submission. The company has engaged in detailed discussions with the FDA, which provided feedback on data organization and formatting", "url": "https://www.stocktitan.net/sec-filings/DBVT/8-k-dbv-technologies-s-a-reports-material-event-f6f90195023e.html", "source_name": "Stock Titan", "published_at": "2026-06-29T20:10:59", "published_display": "29 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Stock Rebounds Nearly 4% and crosses its MM20", "summary": "DBV Technologies stock has rebounded by nearly 4% and crossed its 20-day moving average (MM20), despite the SBF 120 index experiencing a slight decline. The biotech company's stock is trading at \u20ac2.99, one of the highest gains in the SBF 120, although medium-term benchmarks like ", "url": "https://www.ideal-investisseur.fr/en/stock-news/dbv-technologies-stock-rebounds-nearly-4-and-crosses-its-mm20/21696.html", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-29T09:09:25", "published_display": "29 Jun 2026 09:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A40WEX Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This page provides a price target and forecast information for DBV Technologies SA Sponsored ADR (A40WEX), based on analysis from 8 analysts. It includes sections for actuals and estimates for EPS, revenue, and a disclaimer that this information is not investment advice.", "url": "https://www.tradingview.com/symbols/LSX-A40WEX/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T11:11:44", "published_display": "27 Jun 2026 11:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies SA Actuals & Estimates (EURONEXT:DBV)", "summary": "This article provides comprehensive financial data and analyst estimates for DBV Technologies SA (EURONEXT:DBV). It covers the company's current stock price, historical performance, future price forecasts, earnings, revenue, market capitalization, and volatility. Key financial me", "url": "https://www.tradingview.com/symbols/EURONEXT-DBV/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T20:40:46", "published_display": "26 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies SA Actuals & Estimates (GETTEX:DBV)", "summary": "This article provides an overview of DBV Technologies SA (DBV) stock performance, financial estimates, and analyst forecasts. It covers information on its current stock price, historical highs and lows, market capitalization, employee count, and upcoming earnings report. The arti", "url": "https://www.tradingview.com/symbols/GETTEX-DBV/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-06-26T12:40:18", "published_display": "26 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of DBV Technologies SA \u2013 MUN:DBV", "summary": "This article provides an enterprise value to revenue forward for DBV Technologies SA (MUN:DBV) on the Munich Stock Exchange. The content appears to be a stub or a placeholder page from a financial data platform, showing no specific numerical data for the valuation. It indicates t", "url": "https://www.tradingview.com/symbols/MUN-DBV/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:18", "published_display": "26 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for DBV Technologies SA (DBV) stock, including analyst price targets and future predictions. According to 8 analysts, DBV has a 1-year price target of 6.99 EUR, with a max estimate of 9.50 EUR and a min estimate of 1.00 EUR. The company is set to r", "url": "https://www.tradingview.com/symbols/EURONEXT-DBV/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:18", "published_display": "26 Jun 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBVT Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a price target forecast for DBV Technologies S.A. (DBVT) for 2027 based on analyst data. Eight analysts have provided a 1-year price forecast, with a current price target of 40.82. The article also includes sections for actuals and estimates for EPS and Reve", "url": "https://www.tradingview.com/symbols/BOATS-DBVT/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T03:12:07", "published_display": "26 Jun 2026 03:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of DBV Technologies SA \u2013 GETTEX:DBV", "summary": "This page displays financial data for DBV Technologies SA (GETTEX:DBV) focusing on its enterprise value to revenue forward ratio. The content is primarily a data placeholder within a larger financial platform, indicating market status, and providing market data and intellectual p", "url": "https://www.tradingview.com/symbols/GETTEX-DBV/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:12:07", "published_display": "25 Jun 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQZDh0VlVSV0Fqc05KRk5iaUZjTlVDOTBRVk05N0NlV0d6Wk9NMzF4dnpnQVZCLUwxNXUzU3RaU0NEZkNqWmYxNTYyWVZsWWpkTjk5ai13d2dOd3FRYUZTa0F0UzFnTTNlaW9RTmpGYTNTMk1CMUplNGtzdjNjSXAzelRhRjBpOXpBa0VZVGUxZE1XaWxmQllqd3Bn?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Shares Drop Nearly 4% Breaking Below 200-Day Moving Average", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOcGFSbUtMcGtjb0tPd3ZaN0RQc0s3TkphbjlLd2tYRGx1VE9iLWFBUWpoc0NyZVIzVjBnZklSNS1EWDRyYnF6S1VYVkRmY1dDak9sdTJBWldLMVV2azFOem5BSjZvRFNDNnA0UUpuTGZJaUZDYUxZV0I3VkdVYXRGeDJuSWdQSWRPOUdyYnNkQkJVQ3hlNF9kTnlFdVBpakFQVlN2bmtSRW4xN0N0cjM0UEJaaUhKU2lhR3NrSHJaTUxON3FObzEzZlZjMzNkdXM?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies CEO joins Goldman Sachs global healthcare fireside chat", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZ0VYcDk5dzJQWUt0V0d1X3ZNZzNPS2JSa0VsMV83SGxVUlRmb29YdmtPSWtZUmROZmlCTUFnb0dGS3FyS2JrdzdmWTNYczhQNklINE55TFgySjhKakhzNk1BcEpmUlRoRkRmeXo5dS1UeWRFdWkyczQzS25EZWtsSkx2NmlWb2NFMFJtQjZhZEJZREI3N0NhZDZxaEFjQ09IUlc2WEUtWllBbHEweWgxbTB1Q19HZnpBNHNZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "DBV Technologies (DBVT) Upgraded to Buy: What Does It Mean for the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRTZ4TjlYdlJEZkdyS01sQ0c5c0VKVzBfSU5JUGFsMmhzaXFTcnB2c0xCT0pBcU9hSFpVczJiVEhyX01fbGZDbnlUVzBNTno4aXVTZHJONW9KN1ZyX0dDbVJVaDRoNi1hcnhmMFBva1ZTdFhXTlNJQW5fdXN6Q0lvdksxQ2ZzYU0yU1dnTHptczNkUGNNdGlsWXMxc0lScFlK?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Predict a 79.04% Upside in DBV Technologies (DBVT): Here's What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxObUExOW04YzNpRWh3eG1xYnJMWTEtSGNUeDdNeHQzRUdLV3dIR3BkN2FvT2hKOWR4WDUxLU9TMjVwaWtHOXZYZ29QYlVhSDNUbVRhN2p2UExNU2ZMX3JMRmxSeUMxVC14cDV4MU1mMzhCUGNJc2Zla0lycDJEZ1V1ZDFfZi02RDBCbzJ0RVlzT2ZpX2laVmpwQ2tHZF8xaldwQ1QzQzh2UjBLelJzcHRzcA?oc=5", "source_name": "qz.com", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies: A Tough Nut To Crack In A Shrinking Market (NASDAQ:DBVT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOSGd0RzZZaHhCM1RaOE05T01lRUs3cXdRMHFWamZTeTBOY2hsNmJvR2pibG1ULVV0NTZRb05lVFNlV0RscS1xMktndUNwSmZGcHNfakVOcEhsdHYybFhTS1FBdmx6dlFLZVdfeTJzUUZ5M19YV3k0VS1ycW12b284anRyRHlRMjlWcC1nRVAtbVR5NlNLVnFBYkVlal9XZE1rMFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "DBV Technologies: Peanut Allergy Patch Advances to Key Stage", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNbDI2alNuVTBtcEhuY1doQU56ZVgxYTVwLXB4UU50RVhyVkg0eHJ2MjZ6dEpuOE9NNWdGLUN0VjNWZEdHNlhNR0hLaWx5Z3hSdzJfeWJNblBHVmg0NVEzbzBMb2REY3I3LXQtR0FkZU83UWNaWHJQUVlRbThzSFVWb01DQXFNRjFuSTZ0ZnFsems1dFprYjJHNFM0WTh5TVVLZC1NTV9PcVZacVRaS0FuWHV4T0pSMmJ4S0E?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Stock Soars 63% After Hours As Strong Results For Peanut Allergy Patch Clears Path For FDA Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOdFFLczNjcG1wTGlVNjJKNldEUTVBNXMyMFRxejBlLUFaYko2amNHTVRxVXhUdURQWS1PUWJXUnFab3FXWkpWdlBOOFRoT1FVUFc4cGxpblljRHpJYW0zV1VGa184d0hOXzVKdjlUVnJXRG03MjlMeDRFdFNZN3h4NUhtQWlHZHZzM2MxS2V5MUdCUXBxZVh2N1g1YmROOWlib0c5YVNHZUhwVC1RWW8xRDZLY04waHFkX2RyNGtPTEdvZGRHeXNSZkZ3?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why DBV Technologies (ENXTPA:DBV) Is Up 21.7% After Extending Its VIASKIN Peanut Funding Runway", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNRkVvR0NpOVVNZEVCQkZ1TTJWcS1kX1Brekl3TlhmRm9CZG01RTY3SEdDM040azZZRTB3Sy13ZDYwb081QTVucFo2a25GQzU1bHFMczdHaHVoWjJhYnhxemdPTVF4REh6bHRqTXVPdlpLdF82WG81NG16bW5aaU82clRDUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-18T08:00:00+00:00", "published_display": "18 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Announces \u20ac166.7 Million in Gross Proceeds", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwJBVV95cUxPd0RHZ3dDVzRJUnliX09aZGNHeUZObVBFNmdMb3FFRV9rd0VqX3VhWHVlODdKd2tNaHlDVVVFeXNMVzhRSWlBRXJleXdONldhZEpuWkcwTWh4b2x2N3lnbE5qd3pJdXVrT3Y2cUZxX1c5bDNCQmlYRklqcHFzN3Y2cThjdi16MnFWZFRtVlVsUXEtNlk2OEViMjNUdmlnaVo1aFBIazM3RWF5ZHZFYzUtSWsycHJmbmN3R1lhSDhHS0k0T3VFWUh2TDhSUm52NWtMbHV2all5ZDBOcnRMdXNhdEhPTG1iQUxYMUdDa0pxSE1QNWJqT1NFZmNsWHlRR1BEaU5tWGc5c2hmYmZhSm5DbmZwdGhkVVBzc3U1M1NfOUJEMmNYWGFkeWN0ekxDZlNQQmw4SDVwcXJ0LWNOcm4tc2hJbGN4bnVQOFJBYmplaw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dbv Technologies S A (DBVT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE0xZW5iZ1FoaXQ0LXNtcWR6VVRRRUM0Q2gtUGtTYmxvUE11Qzh2VHJoTmIySWZtOTV1N1FOdTcySVVxc3VvbHJGN092ZXVVMENiYWV3?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:30:05+00:00", "published_display": "25 Apr 2025 01:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Announces Financing of up to $306.9", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-03-27T07:00:00+00:00", "published_display": "27 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies (DBVT) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1vdU05ODJoN0VhcjNEdXUxQ1d3ZVFfeTBxOEtEVGtUeGhEYXc3cU13QWxLUy1QQVNldXZPTldBYmFZUlpyU2FHaFpPWmYzR2xFam56VGxyX0FNQ1ZzVVBWM2FoVVpTUQ?oc=5", "source_name": "MarketBeat", "published_at": "2024-05-11T13:49:40+00:00", "published_display": "11 May 2024 13:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies (DBVT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFAtT3ZZbG5yV2xCMld0eFhjRGQ0eVBRMFhJOUQwSHkyTFNiUFRvZ2NqMWNIdUZlMXgyeGpnNTZlRkVuRDVyVXJQSUpXcFROTV9rNVBKai1hQmZkZw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-12T13:58:54+00:00", "published_display": "12 Aug 2016 13:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "DBV Technologies Q2 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/e60da475-1faa-3b60-9017-99d12ca01f96/dbv-technologies-q2-earnings.html", "source_name": "MarketBeat", "published_at": "2026-07-16T23:03:00+00:00", "published_display": "16 Jul 2026 23:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPQ181OW1ta3d0XzRxRFZzMDc0cHFNeXVzUUZRSmZSS0VQbXU1d2VpVU9qVmZXQUtxdkNGeDFvUVRhWnZpb0Ric2ozaWdzeGw2N0w1eDV0WUNJbEZNaEpDd2h6R3FZaHVyb2dXcHl0NFNNSFk1aXlhY3A2eUtFSnA5bE9iekd0NER3cUhTYkprdldoR203MlhpbkFQdmlpZHB1YzFfU2NVWnd1a2xtaGJnSVNJQUtPbXZaZ2JiaXcyUWFPeFk1ZmFxTmdnYjVSbkJyQVdoWkpMNnkzbklUS1QzX1lhZzFmT1pHZEk0?oc=5", "source_name": "markets.businessinsider.com", "published_at": "2026-07-16T21:27:15+00:00", "published_display": "16 Jul 2026 21:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies narrows Q2 loss, funds operations into Q3 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQeUF3VVNkMGZ1WDllcUFXOS1lM01pYUNCRDFIWDJkWmJJcVVudEZqZ3dPQlQwbklhN0pHdHZvampOUGE1NWZXOFRWaWtQWHFPSGdJWlRkc0NmMnV2R2c5LUl2bHIxLTE4ZXJvSk1CbDJUVUt4TnRmeW84YkJFcmRhYkxjZWpEVmdKRjluMlhaLWxjbmZOeXQ4c0Itb1pmclRBT0ZDX2dKbkZLRTJqSU0w?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-16T21:19:49+00:00", "published_display": "16 Jul 2026 21:19", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Announces the Filing of its 2026 Half-Year Report \u2015 Conditions for Accessing or Consulting the Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxPRkdVeW9xS1pIZWtSLWs5azlXMG1vNHhXVldCV0xHLTV3MFdLY01qUjdGSnZYT0syOHF2VU93SUlGbk9mbFhvLVhlUHZVTkpGZGJza1BJLS1oMGlpRUhGVmhuZlhOMWxZODVaZUYtblk0R2tIMmV0VlFWVlliM284WDVabmhGUHNmdjJhSHJ4d1B4OW5pZTFsamFpV2ZuRDAtS3hDQTdtWko5a1J0WnRRcFcwR28wWXBfUXZOYzNMOHpkZDR2N2RURDJ0ek9SLWg1SGxFeHRJTmhPdWkwUDZCejd1ZGpyVnA1V2F2Z3ROcUNBQWUtM05NeTdkZ1JfSlAxR1FaQmxB?oc=5", "source_name": "markets.businessinsider.com", "published_at": "2026-07-16T21:15:13+00:00", "published_display": "16 Jul 2026 21:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Q2 Net Loss Narrows", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/dbv-technologies-q2-net-loss-201457432.html", "source_name": "MT Newswires", "published_at": "2026-07-16T20:14:57+00:00", "published_display": "16 Jul 2026 20:14", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026", "summary": "DBV Technologies announced it will host a conference call and live audio webcast on July 16, 2026, at 5:00 p.m. ET to discuss", "url": "https://www.globenewswire.com/news-release/2026/07/14/3327300/0/en/dbv-technologies-to-report-second-quarter-2026-financial-results-and-business-update-on-july-16-2026.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T16:10:51", "published_display": "15 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Stock Breaks Its \u20ac2.75 Support Ahead of Semi-Annual Results", "summary": "DBV Technologies stock is experiencing a downward trend, breaking its \u20ac2.75 support and trading below its three moving averages ahead of its semi-annual results announcement. The biotech company's stock is down 3.03% during the session, and has fallen nearly 29% over three months", "url": "https://www.ideal-investisseur.fr/en/stock-news/dbv-technologies-stock-breaks-its-eur2-75-support-ahead-of-semi-annual-results/22647.html", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-07-15T10:40:47", "published_display": "15 Jul 2026 10:40", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies to report Q2 2026 results on July 16", "summary": "DBV Technologies is scheduled to release its second quarter 2026 financial results and provide a business update on July 16, 2026. The biopharmaceutical company will host a conference call and live webcast to discuss its performance. The company specializes in developing treatmen", "url": "https://scanx.trade/stock-market-news/companies/dbv-technologies-to-report-q2-2026-results-on-july-16/45613937", "source_name": "scanx.trade", "published_at": "2026-07-14T22:20:32", "published_display": "14 Jul 2026 22:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies' July 16 webcast will cover Q2 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOLWNOZE9wb0RTU3FHVkRqTnZJSnpDeS1uNVRLbTlhRlNtOENTY1ladHBxeUFxUVBTQkxod2xOWS1BV21iT0RFS0tVZmd4RjNDTnBRY0FMajFCeG52X3NzYTlhZU0tSzVhSDdwQnhkaURZQWVEYjdpTURNZXQ5QmJjUHhTOUVQZWlFU1NUQlFyLXZ4T010Slp6dVlkcDVmZmY3NVZGdWJZU0tkb2ZsMzloTi1iYlVZTExsd3JhczVCSWI?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:30:00+00:00", "published_display": "14 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Sets Q2 2026 Results Call July 16 | DBVT Stock News", "summary": "DBV Technologies announced it will report its second quarter 2026 financial results and provide a business update on July 16, 2026. The company will host an investor conference call and live audio webcast at 5:00 p.m. ET to review these results. Key details for investors include ", "url": "https://www.stocktitan.net/news/DBVT/dbv-technologies-to-report-second-quarter-2026-financial-results-and-00cwnf1ic3c7.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:20:32", "published_display": "14 Jul 2026 20:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies S.A. (DBVT) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live quotes and charts for DBV Technologies S.A. (DBVT) stock, showing a current price of $15.53 with a decrease of 2.45%. It also notes that earnings information is not currently available and lacks analyst ratings in the last three months. The content include", "url": "https://www.timothysykes.com/quote/DBVT/", "source_name": "www.timothysykes.com", "published_at": "2026-07-14T19:40:47", "published_display": "14 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in DBV Technologies SA Sponsored ADR Stocks", "summary": "This article lists Exchange Traded Funds (ETFs) that hold DBV Technologies SA Sponsored ADR stocks, sorted by market value. It provides key details for each fund, such as market value, weight, issuer, management style, expense ratio, and AUM, to help investors assess opportunitie", "url": "https://www.tradingview.com/symbols/NASDAQ-DBVT/etfs/", "source_name": "TradingView", "published_at": "2026-07-13T06:10:41", "published_display": "13 Jul 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citizens JMP Maintains DBV Technologies(DBVT.US) With Buy Rating, Maintains Target Price $55", "summary": "Citizens JMP has reiterated its Buy rating for DBV Technologies (DBVT.US), maintaining a target price of $55. This indicates a continued positive outlook on the company's stock performance from the financial institution.", "url": "https://news.futunn.com/en/post/75318636/citizens-jmp-maintains-dbv-technologies-dbvtus-with-buy-rating-maintains", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-08T02:09:29", "published_display": "08 Jul 2026 02:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF", "summary": "DBV Technologies issued its half-year report for its liquidity contract with ODDO BHF, detailing transactions and assets from January 1, 2026, to June 30, 2026. The report showed an increase in DBV Technologies shares in the liquidity account and provided a breakdown of numerous ", "url": "https://www.globenewswire.com/news-release/2026/07/06/3322759/0/en/half-year-report-on-the-dbv-technologies-liquidity-contract-with-oddo-bhf.html", "source_name": "GlobeNewswire", "published_at": "2026-07-07T13:41:13", "published_display": "07 Jul 2026 13:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies S.A.", "summary": "DBV Technologies S.A. has issued its Half-Year Report on the liquidity contract with ODDO BHF for the period of January 1, 2026, to June 30, 2026. The report details the assets held in the liquidity account and the transactions executed within this timeframe, showing significant ", "url": "https://via.ritzau.dk/pressemeddelelse/15036760/dbv-technologies-sa?publisherId=90446", "source_name": "Via Ritzau", "published_at": "2026-07-06T20:14:46", "published_display": "06 Jul 2026 20:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies posts half-year liquidity contract figures", "summary": "DBV Technologies released its half-year report on the liquidity contract with ODDO BHF as of June 30, 2026. The report shows the liquidity account held 146,321 shares and \u20ac396,088.22, with significant trading volumes in the first half of 2026. This contract, governed by AMF Decis", "url": "https://www.stocktitan.net/news/DBVT/half-year-report-on-the-dbv-technologies-liquidity-contract-with-eidhndi1oiqa.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:10:57", "published_display": "06 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Stock Drops Over 2% and Breaks Its Support at \u20ac2.75", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQU3h4YjJvWHZpZzloU2FMdHRGUDd4WmV6OWltRXo4ZTl0bk1EOHk2TWotQTdmYnpsV2JTWkFudzhCU0VBOHdSV3ZVZENFa0tnM1dqVmlWZ19HR1d0ejd3cWstSmRjSjNKOWlGUDFSY0R6YWFuRjJEa2xSSVhYT19jUUtHMEJ0eWdXanB3MkYwNEJEejgwc0ZaT0FMdkdvUHdRTEZMNHF5VG5MSGYteUgtRzJwdnE5RXJKMTBjek1pQkVYWUlUMmhR?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim Maintains DBV Technologies(DBVT.US) With Buy Rating, Maintains Target Price $51", "summary": "Guggenheim has reiterated its Buy rating for DBV Technologies (DBVT.US) and maintained its target price at $51. This indicates continued confidence from the firm in the company's prospects.", "url": "https://news.futunn.com/en/post/75395876/guggenheim-maintains-dbv-technologies-dbvtus-with-buy-rating-maintains-target", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-02T00:13:19", "published_display": "02 Jul 2026 00:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Quick Look at Today's Ratings for DBV Technologies(DBVT.US), With a Forecast Between $40 to $55", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOcW1icEpuLXpVUzAyajEzVDF1UXlkdE5lU0JzV0JRUWUwY2VhMDBfRkZaS2w5V0Q5WjN0S0VaUTFOUFdDSEx6OG4xNXBPeGw5ZDhRbWV3NjlESUluS1dPd3RuVGlndDhSZ1k5ck9USHN3Z2FOQTZZYnRaX28wMzB0SFZoMW5OZ3dmdWNCS0c4dVlsbVZuV1lsQWJR?oc=5", "source_name": "Moomoo", "published_at": "2026-07-01T13:00:01+00:00", "published_display": "01 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Plans Q3 Filing of US Regulatory Application for Viaskin Peanut Patch", "summary": "DBV Technologies announced its intention to file a regulatory application with US health authorities for its Viaskin Peanut patch in the third quarter of 2026. This move follows a pre-submission meeting with the FDA, where the company confirmed the required data for resubmission.", "url": "https://www.moomoo.com/news/post/72229235/dbv-technologies-plans-q3-filing-of-us-regulatory-application-for?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-30T23:09:06", "published_display": "30 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of DBV Technologies SA \u2013 FWB:DBV", "summary": "This page provides financial information for DBV Technologies SA (FWB:DBV) from the Frankfurt Stock Exchange, specifically focusing on its enterprise value to revenue forward. The content indicates that the market is closed and there have been no recent trades. It is presented on", "url": "https://www.tradingview.com/symbols/FWB-DBV/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T19:39:48", "published_display": "30 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies delays BLA filing for VIASKIN\u00ae Peanut Patch in kids 4-7 to Q3 2026 after FDA feedback.", "summary": "DBV Technologies has announced a delay in filing its Biologics License Application (BLA) for the VIASKIN\u00ae Peanut Patch for children aged 4 to 7, pushing it to the third quarter of 2026. This postponement is a result of collaborative discussions with the FDA, aiming to optimize th", "url": "https://pluang.com/en/news-feed/dbv-technologies-update-pengajuan-bla-patch-kacang-anak-anak", "source_name": "Pluang", "published_at": "2026-06-29T21:10:59", "published_display": "29 Jun 2026 21:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Provides BLA Submission Update for the VIASKIN\u00ae Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing", "summary": "DBV Technologies announced an update on its Biologics License Application (BLA) submission for the VIASKIN\u00ae Peanut Patch for children aged four through seven years, following extensive discussions with the FDA. The company received valuable feedback regarding the organization and", "url": "https://www.manilatimes.net/2026/06/30/tmt-newswire/globenewswire/dbv-technologies-provides-bla-submission-update-for-the-viaskin-peanut-patch-in-children-aged-4-through-7-years-working-collaboratively-with-fda-to-optimize-review-process-in-preparation-for-filing/2375236/amp", "source_name": "The Manila Times", "published_at": "2026-06-29T20:10:59", "published_display": "29 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies to file VIASKIN Peanut Patch BLA in Q3 2026 after FDA feedback", "summary": "DBV Technologies plans to submit its Biologics License Application (BLA) for the VIASKIN Peanut Patch in Q3 2026, after incorporating feedback from the FDA. The company engaged in detailed discussions with the FDA, receiving guidance on CMC and biostatistics, with no requests for", "url": "https://www.tradingview.com/news/tradingview:f98bbd4f59988:0-dbv-technologies-to-file-viaskin-peanut-patch-bla-in-q3-2026-after-fda-feedback/", "source_name": "TradingView", "published_at": "2026-06-29T20:10:59", "published_display": "29 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies (NASDAQ: DBVT) targets Q3 2026 for VIASKIN Peanut BLA filing", "summary": "DBV Technologies announced an updated timeline for its Biologics License Application (BLA) for the VIASKIN Peanut Patch, now targeting Q3 2026 for submission. The company has engaged in detailed discussions with the FDA, which provided feedback on data organization and formatting", "url": "https://www.stocktitan.net/sec-filings/DBVT/8-k-dbv-technologies-s-a-reports-material-event-f6f90195023e.html", "source_name": "Stock Titan", "published_at": "2026-06-29T20:10:59", "published_display": "29 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Stock Rebounds Nearly 4% and crosses its MM20", "summary": "DBV Technologies stock has rebounded by nearly 4% and crossed its 20-day moving average (MM20), despite the SBF 120 index experiencing a slight decline. The biotech company's stock is trading at \u20ac2.99, one of the highest gains in the SBF 120, although medium-term benchmarks like ", "url": "https://www.ideal-investisseur.fr/en/stock-news/dbv-technologies-stock-rebounds-nearly-4-and-crosses-its-mm20/21696.html", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-29T09:09:25", "published_display": "29 Jun 2026 09:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A40WEX Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This page provides a price target and forecast information for DBV Technologies SA Sponsored ADR (A40WEX), based on analysis from 8 analysts. It includes sections for actuals and estimates for EPS, revenue, and a disclaimer that this information is not investment advice.", "url": "https://www.tradingview.com/symbols/LSX-A40WEX/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T11:11:44", "published_display": "27 Jun 2026 11:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies SA Actuals & Estimates (EURONEXT:DBV)", "summary": "This article provides comprehensive financial data and analyst estimates for DBV Technologies SA (EURONEXT:DBV). It covers the company's current stock price, historical performance, future price forecasts, earnings, revenue, market capitalization, and volatility. Key financial me", "url": "https://www.tradingview.com/symbols/EURONEXT-DBV/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T20:40:46", "published_display": "26 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies SA Actuals & Estimates (GETTEX:DBV)", "summary": "This article provides an overview of DBV Technologies SA (DBV) stock performance, financial estimates, and analyst forecasts. It covers information on its current stock price, historical highs and lows, market capitalization, employee count, and upcoming earnings report. The arti", "url": "https://www.tradingview.com/symbols/GETTEX-DBV/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-06-26T12:40:18", "published_display": "26 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of DBV Technologies SA \u2013 MUN:DBV", "summary": "This article provides an enterprise value to revenue forward for DBV Technologies SA (MUN:DBV) on the Munich Stock Exchange. The content appears to be a stub or a placeholder page from a financial data platform, showing no specific numerical data for the valuation. It indicates t", "url": "https://www.tradingview.com/symbols/MUN-DBV/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:18", "published_display": "26 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for DBV Technologies SA (DBV) stock, including analyst price targets and future predictions. According to 8 analysts, DBV has a 1-year price target of 6.99 EUR, with a max estimate of 9.50 EUR and a min estimate of 1.00 EUR. The company is set to r", "url": "https://www.tradingview.com/symbols/EURONEXT-DBV/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:18", "published_display": "26 Jun 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBVT Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a price target forecast for DBV Technologies S.A. (DBVT) for 2027 based on analyst data. Eight analysts have provided a 1-year price forecast, with a current price target of 40.82. The article also includes sections for actuals and estimates for EPS and Reve", "url": "https://www.tradingview.com/symbols/BOATS-DBVT/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T03:12:07", "published_display": "26 Jun 2026 03:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of DBV Technologies SA \u2013 GETTEX:DBV", "summary": "This page displays financial data for DBV Technologies SA (GETTEX:DBV) focusing on its enterprise value to revenue forward ratio. The content is primarily a data placeholder within a larger financial platform, indicating market status, and providing market data and intellectual p", "url": "https://www.tradingview.com/symbols/GETTEX-DBV/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:12:07", "published_display": "25 Jun 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQZDh0VlVSV0Fqc05KRk5iaUZjTlVDOTBRVk05N0NlV0d6Wk9NMzF4dnpnQVZCLUwxNXUzU3RaU0NEZkNqWmYxNTYyWVZsWWpkTjk5ai13d2dOd3FRYUZTa0F0UzFnTTNlaW9RTmpGYTNTMk1CMUplNGtzdjNjSXAzelRhRjBpOXpBa0VZVGUxZE1XaWxmQllqd3Bn?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Shares Drop Nearly 4% Breaking Below 200-Day Moving Average", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOcGFSbUtMcGtjb0tPd3ZaN0RQc0s3TkphbjlLd2tYRGx1VE9iLWFBUWpoc0NyZVIzVjBnZklSNS1EWDRyYnF6S1VYVkRmY1dDak9sdTJBWldLMVV2azFOem5BSjZvRFNDNnA0UUpuTGZJaUZDYUxZV0I3VkdVYXRGeDJuSWdQSWRPOUdyYnNkQkJVQ3hlNF9kTnlFdVBpakFQVlN2bmtSRW4xN0N0cjM0UEJaaUhKU2lhR3NrSHJaTUxON3FObzEzZlZjMzNkdXM?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies CEO joins Goldman Sachs global healthcare fireside chat", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZ0VYcDk5dzJQWUt0V0d1X3ZNZzNPS2JSa0VsMV83SGxVUlRmb29YdmtPSWtZUmROZmlCTUFnb0dGS3FyS2JrdzdmWTNYczhQNklINE55TFgySjhKakhzNk1BcEpmUlRoRkRmeXo5dS1UeWRFdWkyczQzS25EZWtsSkx2NmlWb2NFMFJtQjZhZEJZREI3N0NhZDZxaEFjQ09IUlc2WEUtWllBbHEweWgxbTB1Q19HZnpBNHNZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies (DBVT) Upgraded to Buy: What Does It Mean for the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRTZ4TjlYdlJEZkdyS01sQ0c5c0VKVzBfSU5JUGFsMmhzaXFTcnB2c0xCT0pBcU9hSFpVczJiVEhyX01fbGZDbnlUVzBNTno4aXVTZHJONW9KN1ZyX0dDbVJVaDRoNi1hcnhmMFBva1ZTdFhXTlNJQW5fdXN6Q0lvdksxQ2ZzYU0yU1dnTHptczNkUGNNdGlsWXMxc0lScFlK?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Predict a 79.04% Upside in DBV Technologies (DBVT): Here's What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxObUExOW04YzNpRWh3eG1xYnJMWTEtSGNUeDdNeHQzRUdLV3dIR3BkN2FvT2hKOWR4WDUxLU9TMjVwaWtHOXZYZ29QYlVhSDNUbVRhN2p2UExNU2ZMX3JMRmxSeUMxVC14cDV4MU1mMzhCUGNJc2Zla0lycDJEZ1V1ZDFfZi02RDBCbzJ0RVlzT2ZpX2laVmpwQ2tHZF8xaldwQ1QzQzh2UjBLelJzcHRzcA?oc=5", "source_name": "qz.com", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies: A Tough Nut To Crack In A Shrinking Market (NASDAQ:DBVT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOSGd0RzZZaHhCM1RaOE05T01lRUs3cXdRMHFWamZTeTBOY2hsNmJvR2pibG1ULVV0NTZRb05lVFNlV0RscS1xMktndUNwSmZGcHNfakVOcEhsdHYybFhTS1FBdmx6dlFLZVdfeTJzUUZ5M19YV3k0VS1ycW12b284anRyRHlRMjlWcC1nRVAtbVR5NlNLVnFBYkVlal9XZE1rMFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies: Peanut Allergy Patch Advances to Key Stage", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNbDI2alNuVTBtcEhuY1doQU56ZVgxYTVwLXB4UU50RVhyVkg0eHJ2MjZ6dEpuOE9NNWdGLUN0VjNWZEdHNlhNR0hLaWx5Z3hSdzJfeWJNblBHVmg0NVEzbzBMb2REY3I3LXQtR0FkZU83UWNaWHJQUVlRbThzSFVWb01DQXFNRjFuSTZ0ZnFsems1dFprYjJHNFM0WTh5TVVLZC1NTV9PcVZacVRaS0FuWHV4T0pSMmJ4S0E?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Stock Soars 63% After Hours As Strong Results For Peanut Allergy Patch Clears Path For FDA Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOdFFLczNjcG1wTGlVNjJKNldEUTVBNXMyMFRxejBlLUFaYko2amNHTVRxVXhUdURQWS1PUWJXUnFab3FXWkpWdlBOOFRoT1FVUFc4cGxpblljRHpJYW0zV1VGa184d0hOXzVKdjlUVnJXRG03MjlMeDRFdFNZN3h4NUhtQWlHZHZzM2MxS2V5MUdCUXBxZVh2N1g1YmROOWlib0c5YVNHZUhwVC1RWW8xRDZLY04waHFkX2RyNGtPTEdvZGRHeXNSZkZ3?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why DBV Technologies (ENXTPA:DBV) Is Up 21.7% After Extending Its VIASKIN Peanut Funding Runway", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNRkVvR0NpOVVNZEVCQkZ1TTJWcS1kX1Brekl3TlhmRm9CZG01RTY3SEdDM040azZZRTB3Sy13ZDYwb081QTVucFo2a25GQzU1bHFMczdHaHVoWjJhYnhxemdPTVF4REh6bHRqTXVPdlpLdF82WG81NG16bW5aaU82clRDUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-18T08:00:00+00:00", "published_display": "18 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Announces \u20ac166.7 Million in Gross Proceeds", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwJBVV95cUxPd0RHZ3dDVzRJUnliX09aZGNHeUZObVBFNmdMb3FFRV9rd0VqX3VhWHVlODdKd2tNaHlDVVVFeXNMVzhRSWlBRXJleXdONldhZEpuWkcwTWh4b2x2N3lnbE5qd3pJdXVrT3Y2cUZxX1c5bDNCQmlYRklqcHFzN3Y2cThjdi16MnFWZFRtVlVsUXEtNlk2OEViMjNUdmlnaVo1aFBIazM3RWF5ZHZFYzUtSWsycHJmbmN3R1lhSDhHS0k0T3VFWUh2TDhSUm52NWtMbHV2all5ZDBOcnRMdXNhdEhPTG1iQUxYMUdDa0pxSE1QNWJqT1NFZmNsWHlRR1BEaU5tWGc5c2hmYmZhSm5DbmZwdGhkVVBzc3U1M1NfOUJEMmNYWGFkeWN0ekxDZlNQQmw4SDVwcXJ0LWNOcm4tc2hJbGN4bnVQOFJBYmplaw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dbv Technologies S A (DBVT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE0xZW5iZ1FoaXQ0LXNtcWR6VVRRRUM0Q2gtUGtTYmxvUE11Qzh2VHJoTmIySWZtOTV1N1FOdTcySVVxc3VvbHJGN092ZXVVMENiYWV3?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:30:05+00:00", "published_display": "25 Apr 2025 01:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies Announces Financing of up to $306.9", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-03-27T07:00:00+00:00", "published_display": "27 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies (DBVT) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1vdU05ODJoN0VhcjNEdXUxQ1d3ZVFfeTBxOEtEVGtUeGhEYXc3cU13QWxLUy1QQVNldXZPTldBYmFZUlpyU2FHaFpPWmYzR2xFam56VGxyX0FNQ1ZzVVBWM2FoVVpTUQ?oc=5", "source_name": "MarketBeat", "published_at": "2024-05-11T13:49:40+00:00", "published_display": "11 May 2024 13:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DBV Technologies (DBVT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFAtT3ZZbG5yV2xCMld0eFhjRGQ0eVBRMFhJOUQwSHkyTFNiUFRvZ2NqMWNIdUZlMXgyeGpnNTZlRkVuRDVyVXJQSUpXcFROTV9rNVBKai1hQmZkZw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-12T13:58:54+00:00", "published_display": "12 Aug 2016 13:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPV1hqSFhQM3VfYlNsdldfeVQ1dEdNNzI3S1RTaFJNSThrOXlPSWpMTlR5WWVxNnNsTzhTVGVvTE94R18wa1A0OUdFczBlcTIzeUFBZUt6VVJJMjNqNks3dmRUSzB4cE40anpNekJwUXAwcTFEcVh4QVZCYURXY2w4b2thdk5KZ3ZJMnI1REJObXo5UDdISXVCU1Z2ZVZoVmJpbnEzaDVWVmpGQVNFZzRXYnp0SWRRWWZGSnZnWlJ4aEloNmJBNGRMVFRjb3ZRbmV3QXF5S0pvTV9xNnpaMWV1Z1ZtM3lPdV9RcEdURHlfZFphdjlicEJndW0ybHNBa205?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-13T03:32:00+00:00", "published_display": "13 Jul 2026 03:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 99, "total_relevant": 56, "sentiment_summary": {"positive": 11, "negative": 5, "neutral": 40, "score": 52, "total": 56, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 75, "events": [{"event": "earnings", "label": "Earnings", "weight": 13.06, "count": 26}, {"event": "general", "label": "Market update", "weight": 10.8, "count": 19}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 1.65, "count": 3}], "positive_events": 11, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 16.49, "latest_week": "2026-07-10", "one_week_move": 4.2, "four_week_move": -5.3, "twelve_week_move": -22.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.540679, "market_dynamics_buy_signal": false, "relative_strength": -13.528185, "fair_value_gap": 58.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 37.0021, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.2% over one week, -5.3% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 11}, {"label": "Market source", "count": 8}, {"label": "Stock Titan", "count": 6}, {"label": "Id\u00e9al Investisseur", "count": 5}, {"label": "GlobeNewswire", "count": 4}, {"label": "MarketBeat", "count": 3}, {"label": "markets.businessinsider.com", "count": 2}, {"label": "scanx.trade", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 47}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 26}, {"label": "Market update", "count": 19}, {"label": "Analyst action", "count": 5}, {"label": "Deals and strategy", "count": 3}, {"label": "Guidance", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "47", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.2% over one week, -5.3% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "DBV Technologies Q2 Earnings Call Highlights"}], "updated_at": "2026-07-17T03:37:24.948497+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}